Induction of EAE in mice wtih recombinant human MOG, and treatment of EAE with a MOG peptide

Journal of Neuroimmunology

Volumn 75, Issue 1-2, 1997, Pages 169-173

  Devaux, Brigitte ^a,b   Enderlin, Fran ^a   Wallner, Barbara ^a   Smilek, Dawn E ^a  

^a ImmuLogic Pharmaceutical Corporation   (United States)

^b GENENTECH INC   (United States)

Author keywords

experimental autoimmune encephalomyelitis; myelin oligodendrocyte glycoprotein; peptide therapy; T cell epitope

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; LYMPH NODE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; CELL DIVISION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; IMMUNOTHERAPY; LYMPHOCYTES; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS;

EID: 0030893962     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00019-2     Document Type: Article

References (20)

1. Amiguet, P., Gardinier, M.V., Zanetta, J.-P. and Matthieu, J.-M. (1992) Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein. J. Neurochem. 58, 1676-1682.
2. Amor, S., Groome, N., Linington, C., Morris, M.M., Dornmair, K., Gardinier, M.V., Matthieu, J.-M. and Baker, D. (1994) Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153, 4349-4356.
3. Brocke, S., Gijbeis, K., Allegretta, M., Ferber, I., Piercy, C., Blankenstein, T., Martin, R., Utz, U., Karin, N., Mitchell, D., Veromaa, T., Walsman, A., Gaur, A., Conlon, P., Ling, N., Fairchild, P., Wraith, D.C., O'Garra, A., Fathman, C.G. and Steinman, L. (1996) Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379, 343-346.
4. Critchfield, J.M., Racke, M.K., Zúñiga-Pflücker, J.C., Cannella, B., Raine, C.S., Goverman, J., Lenardo, M.J. (1994) T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263, 1139-1143.
5. Fritz, R.B. and McFarlin, D.E. (1989) Encephalitogenic epitopes of myelin basic protein. Chem. Immunol. 46, 101-125.
6. Gardinier, M.V., Amiguet, P., Linington, C. and Matthieu, J.-M. (1992) Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J. Neurosci. Res. 33, 177-187.
7. Gaur, A., Wiers, B., Liu, A., Rothbard, J. and Fathman, C.G. (1992) Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258, 1491-1494.
8. Johns, T.G., Kerlero de Rosbo, N., Menon, K.K., Abo, S., Gonzales, M.F. and Bernard, C.C.A. (1995) Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154, 5536-5541.
9. Karin, N., Mitchell, D.J., Brocke, S., Ling, N. and Steinman, L. (1994) Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon y and tumor necrosis factor α production. J. Exp. Med. 180: 2227-2237.
10. Kerlero de Rosbo, N., Mendel, I. and Ben-Nun, A. (1995) Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur. J. Immunol. 25, 985-993.
11. Linington, C., Webb, M. and Woodhams, P. (1984) A novel myelin-associated glycoprotein defined by a mouse monclonal antibody. J. Neuroimmunol. 6, 387-396.
12. Linington, C., Berger, T., Perry, L., Weerth, S., Hinze-Selch, D., Zhang, Y., Lu, H., Lassman, H. and Wekerle, H. (1993) T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23, 1364-1372.
13. Martin, R., McFarland, H.F. and McFarlin, D.E. (1992) Immunological aspects of demyelinating diseases. Ann. Rev. Immunol. 10, 153-187.
14. Martin, R. and McFarland, H.F. (1995) Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. in Clin. Lab. Sci. 32, 121-182.
15. b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur. J. Immunol. 25, 1951-1959.
16. Metzler, B. and Wraith, D.C. (1993) Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5, 1159-1165.
17. Samson, M.F. and Smilek, D.E. (1995) Reversal of acute experimental autoimmune encephalomyelitis and Prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes. J. Immunol. 155, 2737-2746.
18. Smilek, D.E., Wraith, D.C., Hodgkinson, S., Dwivedy, S., Stienman, L. and McDevitt, H.O. (1991) A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 88, 9633-9637.
19. Wraith, D.C., Smilek, D.E., Mitchell, D.J., Steinman, L. and McDevitt, H.O. (1989) Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59, 247-255.
20. Zamvil, S.S. and Steinman, L. (1990) The T lymphocyte in experimental allergic encephalomyelitis. Ann. Rev. Immunol. 8, 579-621.